- Home
- QNCX vs PAVS Comparison
QNCX vs PAVS Comparison
Compare QNCX & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNCX | PAVS |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.5M | 5.5M |
| IPO Year | 2019 | 2018 |
Fundamental Metrics
Financial Performance| Metric | QNCX | PAVS |
|---|---|---|
| Price | $29.96 | $4.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $75.43 | N/A |
| AVG Volume (30 Days) | ★ 14.5K | 11.2K |
| Earning Date | 11-11-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $541.46 |
| Revenue Next Year | N/A | $1.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $0.02 |
| 52 Week High | $35.41 | $26.69 |
Technical Indicators
Market Signals| Indicator | QNCX | PAVS |
|---|---|---|
| Relative Strength Index (RSI) | 57.40 | 39.15 |
| Support Level | $29.95 | $3.86 |
| Resistance Level | $34.58 | $5.55 |
| Average True Range (ATR) | 2.35 | 0.23 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 86.14 | 10.00 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.